Sam Schulman, Donald M Arnold, Charlotte A Bradbury, Lisa Broxmeyer, Jean Marie Connors, Anna Falanga, Toshiaki Iba, Scott Kaatz, Jerrold H Levy, Saskia Middeldorp, Tracy Minichiello, Ishac Nazy, Eduardo Ramacciotti, Helaine E Resnick, Charles Marc Samama, Michelle Sholzberg, Jecko Thachil, Ryan Zarychanski, Alex C Spyropoulos
Based on emerging evidence from the COVID-19 pandemic, the International Society on Thrombosis and Haemostasis (ISTH) guidelines for antithrombotic treatment in COVID-19 were published in 2022. Since then, at least 16 new randomized controlled trials have contributed additional evidence, which necessitated a modification of most of the previous recommendations. We used again the American College of Cardiology Foundation/American Heart Association methodology for assessment of level of evidence (LOE) and class of recommendation (COR)...
March 18, 2024: Journal of Thrombosis and Haemostasis: JTH